Xue; Tongtong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xue; Tongtong.The latest application filed is for "solid form of aromatic compound and preparation method therefor".

Company Profile

9.4.19

Xue; Tongtong - Sichuan CN
XUE; Tongtong - Chengdu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant bispecific antibodies to PD-L1 and CTLA-4 Grant 11,421,029 - Xue , et al. August 23, 2	2022-08-23
Solid Form Of Aromatic Compound And Preparation Method Therefor App 20220220075 - YI; Shidong ; et al.	2022-07-14
Anti-fxi/fxia Antibody And Use Thereof App 20220162338 - TIAN; Haijun ; et al.	2022-05-26
Benzothiophene Compound, Preparation Method Therefor And Use Thereof App 20220162199 - LIU; Jinming ; et al.	2022-05-26
Heterocyclic Compound, Pharmaceutical Composition Comprising Same, Preparation Method Therefor, And Use Thereof App 20220144847 - Chen; Zhonghui ; et al.	2022-05-12
Nitrogen-containing Fused Cyclic Compound, Preparation Method Therefor And Use Thereof App 20220056043 - LI; GUIYING ; et al.	2022-02-24
Aminopyridine Compound, Preparation Method Therefor And Use Thereof App 20220017483 - LIU; Jinming ; et al.	2022-01-20
Anti-erbb2 Antibody-drug Conjugate And Composition Thereof, Preparation Method Therefor, And Use Thereof App 20220008553 - XUE; Tongtong ; et al.	2022-01-13
Cytotoxin and conjugate, uses of same and preparation method therefor Grant 11,207,420 - Cai , et al. December 28, 2	2021-12-28
Substituted Aryl Compound And Preparation Method Therefor And Use Thereof App 20210395226 - LIU; Jinming ; et al.	2021-12-23
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof Grant 11,136,413 - Li , et al. October 5, 2	2021-10-05
Anti-erbb2 Antibody-drug Conjugate And Composition Thereof, Preparation Method Therefor, And Use Thereof App 20210252006 - XUE; Tongtong ; et al.	2021-08-19
Antibody Against Tim-3 And Application Thereof App 20210238282 - Li; Qiang ; et al.	2021-08-05
Bioactive Conjugate, Preparation Method Therefor And Use Thereof App 20210101906 - CAI; Jiaqiang ; et al.	2021-04-08
Use of Anti-HER2 Antibody-Drug Conjugate in Cancer Treatment App 20210000970 - SONG; Hongmei ; et al.	2021-01-07
Bioactive Conjugate, Preparation Method Therefor And Use Thereof App 20200347075 - CAI; Jiaqiang ; et al.	2020-11-05
Anti-lag-3 Antibody And Use Thereof App 20200347131 - XUE; Tongtong ; et al.	2020-11-05
Recombinant Bispecific Antibody App 20200216538 - XUE; Tongtong ; et al.	2020-07-09
Cytotoxin And Conjugate, Uses Of Same And Preparation Method Therefor App 20200179529 - CAI; Jiaqiang ; et al.	2020-06-11
Pdl-1 Antibody, Pharmaceutical Composition Thereof, And Uses Thereof App 20200010570 - Li; Baiyong ; et al.	2020-01-09
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof Grant 10,465,014 - Li , et al. No	2019-11-05
Anti-erbb2 Antibody-drug Conjugate And Composition Thereof, Preparation Method Therefor, And Application Thereof App 20190076438 - XUE; Tongtong ; et al.	2019-03-14
Pdl-1 Antibody, Pharmaceutical Composition Thereof, And Uses Thereof App 20180305464 - Li; Baiyong ; et al.	2018-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.